1. Sim FH, Chao EY. Prosthetic replacement of the knee and a large segment of the femur or tibia. J Bone Joint Surg Am. 1979; 61:887–892.
Article
2. Roberts P, Chan D, Grimer RJ, Sneath RS, Scales JT. Prosthetic replacement of the distal femur for primary bone tumours. J Bone Joint Surg Br. 1991; 73:762–769.
Article
3. Kotz R, Ritschl P, Trachtenbrodt J. A modular femur-tibia reconstruction system. Orthopedics. 1986; 9:1639–1652.
Article
4. Lewis MM, Bloom N, Esquieres EM, Kenan S, Ryniker DM. The expandable prosthesis. An alternative to amputation for children with malignant bone tumors. AORN J. 1987; 46:457–470.
5. Han I, Lee SH, Cho HS, Oh JH, Kim HS. Use of expandable prostheses in malignant bone tumors in children. J Korean Bone Joint Tumor Soc. 2008; 14:10–16.
6. Abudu A, Grimer R, Tillman R, Carter S. The use of prostheses in skeletally immature patients. Orthop Clin North Am. 2006; 37:75–84.
Article
7. Nystrom LM, Morcuende JA. Expanding endoprosthesis for pediatric musculoskeletal malignancy: current concepts and results. Iowa Orthop J. 2010; 30:141–149.
8. Raiss P, Kinkel S, Sauter U, Bruckner T, Lehner B. Replacement of the proximal humerus with MUTARS tumor endoprostheses. Eur J Surg Oncol. 2010; 36:371–377.
Article
9. King JJ, Nystrom LM, Reimer NB, Gibbs CP Jr, Scarborough MT, Wright TW. Allograft-prosthetic composite reverse total shoulder arthroplasty for reconstruction of proximal humerus tumor resections. J Shoulder Elbow Surg. 2015; 08. 06. Published online. DOI:
10.1016/j.jse.2015.06.021.
Article
10. Capanna R, Scoccianti G, Frenos F, Vilardi A, Beltrami G, Campanacci DA. What was the survival of megaprostheses in lower limb reconstructions after tumor resections? Clin Orthop Relat Res. 2015; 473:820–830.
Article
11. Kim HS, Kim KJ, Han I, Oh JH, Lee SH. The use of pasteurized autologous grafts for periacetabular reconstruction. Clin Orthop Relat Res. 2007; 464:217–223.
Article
12. Capanna R, Morris HG, Campanacci D, Del Ben M, Campanacci M. Modular uncemented prosthetic reconstruction after resection of tumours of the distal femur. J Bone Joint Surg Br. 1994; 76:178–186.
Article
13. Flint MN, Griffin AM, Bell RS, Ferguson PC, Wunder JS. Aseptic loosening is uncommon with uncemented proximal tibia tumor prostheses. Clin Orthop Relat Res. 2006; 450:52–59.
Article
14. Pala E, Trovarelli G, Calabrò T, Angelini A, Abati CN, Ruggieri P. Survival of modern knee tumor megaprostheses: failures, functional results, and a comparative statistical analysis. Clin Orthop Relat Res. 2015; 473:891–899.
Article
15. Palumbo BT, Henderson ER, Groundland JS, et al. Advances in segmental endoprosthetic reconstruction for extremity tumors: a review of contemporary designs and techniques. Cancer Control. 2011; 18:160–170.
Article
16. Hardes J, von Eiff C, Streitbuerger A, et al. Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma. J Surg Oncol. 2010; 101:389–395.
Article
17. Chandrasekar CR, Grimer RJ, Carter SR, Tillman RM, Abudu A, Buckley L. Modular endoprosthetic replacement for tumours of the proximal femur. J Bone Joint Surg Br. 2009; 91:108–112.
Article
18. Bernthal NM, Greenberg M, Heberer K, Eckardt JJ, Fowler EG. What are the functional outcomes of endoprosthestic reconstructions after tumor resection? Clin Orthop Relat Res. 2015; 473:812–819.
Article
19. Menendez LR, Ahlmann ER, Kermani C, Gotha H. Endoprosthetic reconstruction for neoplasms of the proximal femur. Clin Orthop Relat Res. 2006; 450:46–51.
Article
20. Houdek MT, Wagner ER, Wilke BK, Wyles CC, Taunton MJ, Sim FH. Long term outcomes of cemented endoprosthetic reconstruction for periarticular tumors of the distal femur. Knee. 2015; 09. 08. Published online. DOI:
10.1016/j.knee.2015.08.010.
Article
21. Malawer MM, Chou LB. Prosthetic survival and clinical results with use of large-segment replacements in the treatment of high-grade bone sarcomas. J Bone Joint Surg Am. 1995; 77:1154–1165.
Article
22. Bergin PF, Noveau JB, Jelinek JS, Henshaw RM. Aseptic loosening rates in distal femoral endoprostheses: does stem size matter? . Clin Orthop Relat Res. 2012; 470:743–750.
Article
23. Kawai A, Backus SI, Otis JC, Healey JH. Interrelationships of clinical outcome, length of resection, and energy cost of walking after prosthetic knee replacement following resection of a malignant tumor of the distal aspect of the femur. J Bone Joint Surg Am. 1998; 80:822–831.
Article
24. Puchner SE, Kutscha-Lissberg P, Kaider A, et al. Outcome after reconstruction of the proximal tibia: complications and competing risk analysis. PLoS One. 2015; 10:e0135736.
25. Lee SH, Kim HS, Park YB, Rhie TY, Lee HK. Prosthetic reconstruction for tumours of the distal tibia and fibula. J Bone Joint Surg Br. 1999; 81:803–807.
Article